OmniSYS Names New CEO
September 14, 2015DALLAS, TX – September 14, 2015 – OmniSYS, LLC, a leading provider of billing, compliance, and patient-adherence solutions for pharmacies and medical equipment suppliers, announced today that John G. King is joining the company as chief executive officer, effective September 21, 2015. King, who previously served as President of Standard Register’s healthcare business, replaces interim chief executive officer Andy Kieffer, who will continue to serve on the OmniSYS Board of Directors.
“The OmniSYS Board of Directors launched a national search and considered many highly qualified candidates, but in the end John King demonstrated the kind of vision and innovative spirit combined with operational skills and sales experience that the company needs to continue on its growth trajectory,” Kieffer said. “His experience and leadership will be critical as we continue to develop new products and services for the pharmacy and HME/DME markets.”
King has more than 20 years of sales and operational leadership experience in healthcare and information technology. Prior to joining OmniSYS, he was the president of Standard Register’s healthcare business. He also held various leadership positions at MedAssets and McKesson Corporation, where he developed and executed strategies to drive growth and ensure operational excellence. Earlier in his career he gained diverse experience working at both IDX Systems Corporation (now GE Healthcare) and Shared Medical Systems (now Siemens Healthcare). King holds a achelor of arts with honors from the Virginia Military Institute.
“Healthcare is undergoing a significant transformation and pharmacies are playing a central role,” King said. “With OmniSYS unique insight into pharmacy data and intimate understanding of clinical workflows, we can help redefine the healthcare experience through innovative technology and service excellence. I’m eager to lead OmniSYS in that mission.”
Recent Press Releases
-
Oct 8, 2026
Diagnostic Lab Claim Denials Jumped 40% in 2025, New XiFin Research Report Finds
-
Sep 30, 2026
XiFin Launches Fourth Annual Pharmacy Transformation Outlook Survey as Legislative Action Moves to Reshape Pharmacist-Provided Care
-
Sep 24, 2026
Frost Radar™ Recognizes XiFin as the Only AI-enabled Ancillary Healthcare RCM Specialist Among Leading North American Providers
-
Aug 25, 2026
XiFin Research Quantifies Millions in Recoverable Revenue Across Ancillary Healthcare Revenue Cycles
-
Aug 18, 2026
XiFin Appoints Chris Martin as Chief Product Officer, Continues Building Award-Winning Leadership Team